Biotheryx Announces U.S. FDA Clearance of Investigational New Drug Application for BTX-9341, a First-In-Class, Dual Bifunctional Degrader of CDK4/6 ...Middle East

SAN DIEGO, May 7, 2024 /PRNewswire/ -- Biotheryx, Inc., a biopharmaceutical company discovering and developing a portfolio of first-in-class protein degraders with a focus on validated targets in cancer and inflammatory disease, today announced that the U.S. Food and Drug Administration...

Hence then, the article about biotheryx announces u s fda clearance of investigational new drug application for btx 9341 a first in class dual bifunctional degrader of cdk4 6 was published today ( Tuesday 07/05/2024 - 03:04 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biotheryx Announces U.S. FDA Clearance of Investigational New Drug Application for BTX-9341, a First-In-Class, Dual Bifunctional Degrader of CDK4/6 )

Also on site :

• Costco’s $25 Glassware Set Is Giving Anthropologie Vibes for Less
• Pentagon wants killer AI without safeguards – Reuters
• '90s Grunge Rock Band's Hits Revived in Special Tribute Performance